Picture of Auxly Cannabis logo

XLY — Auxly Cannabis News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSuper Stock

Canada's Auxly Cannabis Q3 revenue rises on higher volumes, pricing

Canada's Auxly Cannabis Q3 revenue rises on higher volumes, pricing 


Overview

  • Canada cannabis producer's Q3 revenue rose 24% yr/yr to C$49.5 mln

  • Adjusted EBITDA for Q3 climbed 29% to C$15.8 mln

  • Net income fell yr/yr due to prior-year one-time gain, but underlying profit improved


Outlook

  • Auxly plans capital investments of up to C$30 mln through 2028 to boost production capacity

  • Company expects to commit C$10 mln to C$12 mln of cash flow to capital projects in 2026

  • Auxly sees Canadian cannabis market benefiting from rising social acceptability and international demand


Result Drivers

  • CORE PORTFOLIO VOLUMES - Co said revenue growth was driven by higher incremental volumes across its core portfolio

  • FLOWER PRICING - Improved pricing across the flower portfolio contributed to higher net revenue

  • CULTIVATION AND MANUFACTURING - Stable gross margin attributed to improvements in cultivation and manufacturing processes, strategic procurement, favorable product mix and lower distillate input costs


Company press release: ID:nCNWZPtWwa


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Beat

C$49.50 mln

C$45.75 mln (2 Analysts)

Q3 Net Income

C$13.60 mln

Q3 Adjusted EBITDA

C$15.80 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the pharmaceuticals peer group is "buy"

  • Wall Street's median 12-month price target for Auxly Cannabis Group Inc is C$4.50, about 26.8% above its November 11 closing price of C$3.55

  • The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 19 three months ago


Reuters Recommended Reads

  • Nov 9 - Canada cannabis producer Village Farms' Q3 sales beat on higher exports

  • Nov 10 - Cannabis platform Vireo Growth's Q3 revenue jumps on acquisitions

  • Nov 9 - Canada's Zymeworks raises 2026 revenue and EBITDA guidance


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Auxly Cannabis

See all news